iRobot Corporation (NASDAQ:IRBT) represented a move of -0.26 percent or $-0.37 per share and closed its previous day trading session at $64.36. 1.53 Million Shares were traded in the last trading session with an Average Volume of 1.2 Million Shares. The stock currently has a Market Capitalization of 1.84 Billion.
iRobot Corporation the leading global consumer robot company, designs and builds robots that empower people to do more both inside and outside of the home. iRobot created the home robot cleaning category with the introduction of its Roomba Vacuuming Robot in 2002. iRobot’s product line, including the Roomba and the Braava family of mopping robots, feature proprietary technologies and advanced concepts in cleaning, mapping and navigation. iRobot’s engineers are building an ecosystem of robots and data to enable the smart home. The company has developed some of the world’s most important robots, and has a rich history steeped in innovation. Its robots have revealed mysteries of the Great Pyramid of Giza, found harmful subsea oil in the Gulf of Mexico, and saved thousands of lives in areas of conflict and crisis around the globe. iRobot brought the first self-navigating FDA-approved remote presence robots to hospitals and introduced the first practical home robot with Roomba, in home cleaning.
The stock traded between $ 54.72 and $109.78 over 1-Year time period showing its price to sales ratio of 2.08. iRobot Corporation (NASDAQ:IRBT) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-18.7 and 200-Day Simple Moving Average of $-23.98. Its Price to Free Cash Flow is 22.6 and Price to Book of 3.91.
Analyst’s recommended the stock as 3 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, iRobot Corporation (NASDAQ:IRBT) reported its Actual EPS of $0.16/share. The analysts offering Earnings Estimates for the company were believing that iRobot Corporation could bring EPS of $0.25/share. The difference between Actual EPS and Estimated EPS was -0.09 Percent. Thus showing an Earnings Surprise of -36 Percent.
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)
In the last trading session, Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) added its value by -12.92% closing at the price of $8.09. The stock currently has market capitalization of 855.19 Million, with average volume of 656.97 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) is showing beta of 0.48. This particular value of beta suggests that Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) has historically moved 48% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) is at $-1.27.
The stock currently has RSI of 27.86. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Lexicon Genetics Incorporated is a leader in defining the functions of genes for drug discovery using large-scale knockout mouse technology. Lexicon has invented high-throughput gene trapping technology to discover thousands of genes and expand its OmniBank library of tens of thousands of mouse clones. The Company uses an integrated platform of functional genomic technologies to accelerate large-scale analysis of mammalian gene function for drug discovery.
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) topped its 52-week high price of $18.00 on 06/26/17 and 52-Week Low Price of $ 8.01 on 02/14/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 6.77% and monthly volatility of 5.57% respectively.